Perspective · Sep 2023
Research articlePublished 1 Sep 2018
Clinical significance of Aldh1a1, Cd133 and Oct 4 in breast cancer and its association with epithelial mesenchymal transition
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: To evaluate role of stem cell markers Aldh1a1, Cd133 and Oct 4 and its association with Epithelial Mesenchymal Transition (EMT) markers in breast cancer patients. Materials and method: Total of 100 breast cancer patients were enrolled. These markers were studied by immunohistochemistry method and correlated with clinicopathological parameters, ER, PR, HER2 and disease status. Results: Aldh1a1 expression was noted in 43% patients with breast cancer and higher incidence was found in patients with age >45 years (p=0.02), postmenopausal status, IDC+ mucinous carcinoma and papillary carcinoma histological type and ER positivity. Cd133 expression was noted in 87% patients with breast cancer and showed significant positive correlation with Oct 4 expression (p=0.002) and vimentin (p=0.003). Univariate survival analysis showed an association of Cd133 negative expression with reduced DFS and OS. Oct 4 expression was noted in 84% patients with breast cancer and associated with poor OS. In multivariate survival analysis, for DFS lymph node entered at step 1 and Cd133 negative expression entered at step 2. For OS, lymph node entered at step 1, Cd133 negative expression entered at step 2 and Oct 4 positive expression entered at step 3. Conclusion: Cd133 and Oct 4 emerged as independent biomarkers to predict worse prognosis in breast cancer patients. Cd133 may have a role in EMT and could be used as a drug target.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Genetics and Genomics.
Perspective · Sep 2023
Suggestive findings of FMR1 disorder and diagnosis
Commentary · Sep 2023
Brief note on muscular dystrophy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Genetics and Genomics
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Joshi Gr”
- BylineArticles whose byline prints “Patel Na”
- BylineArticles whose byline prints “Vora Hh”
